Literature DB >> 27870927

CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells.

Mariko Watanabe1, Kazumi Nakano2, Marshall E Kadin3, Masaaki Higashihara1, Toshiki Watanabe2, Ryouichi Horie4.   

Abstract

Previous studies report deregulation of multiple signaling pathways in classic Hodgkin lymphoma (cHL) cells. However, the mechanisms of how these pathways are integrated are not fully understood. Herein, we show involvement of cHL hallmark antigen CD30 in this process. CD30 facilitates phosphorylation of heat shock factor 1, activates heat shock promoter element, and induces heat shock protein (HSP) 90. CD30 repression and subsequent inhibition of HSP90 suppresses NF-κB, extracellular signal-regulated kinase, AKT, and STAT pathways in cHL cell lines. Thus, CD30-mediated induction of HSP90 appears to serve as a central hub for integration of intracellular signaling in cHL cells. We also show that CD30 induces HSP90 through phosphorylation of heat shock factor 1 via c-Jun N-terminal kinase in cHL cells. Although anaplastic large-cell lymphoma (ALCL) also is associated with CD30 overexpression, our experiments reveal that HSP90 induction in ALCL-bearing nucleophosmin-anaplastic lymphoma kinase (ALK) does not depend on CD30 but instead on ALK via c-Jun N-terminal kinase. Together, these results highlight a novel role for CD30 in mediating integration of signaling pathways of cHL cells while being replaced in this function by ALK in ALCL cells.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27870927     DOI: 10.1016/j.ajpath.2016.09.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  2 in total

1.  Targeting Hodgkin and Reed-Sternberg Cells with an Inhibitor of Heat-Shock Protein 90: Molecular Pathways of Response and Potential Mechanisms of Resistance.

Authors:  Priscilla Segges; Stephany Corrêa; Bárbara Du Rocher; Gabriela Vera-Lozada; Flavia Krsticevic; Debora Arce; Cinthya Sternberg; Eliana Abdelhay; Rocio Hassan
Journal:  Int J Mol Sci       Date:  2018-03-13       Impact factor: 5.923

Review 2.  Heat Shock Proteins in Lymphoma Immunotherapy.

Authors:  Zarema Albakova; Yana Mangasarova; Alexander Sapozhnikov
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.